WHO confirms almost 500 Ebola infections in Central Africa Amid rising health concerns

Central Africa is grappling with a rapidly escalating Ebola virus disease (EVD) outbreak, with nearly 500 confirmed cases and at least 88 fatalities across the Democratic Republic of Congo (DRC) and Uganda. This resurgence is driven by the rare Bundibugyo virus (BDBV) strain, for which no licensed vaccine or approved specific treatment currently exists, intensifying global health anxieties. The World Health Organization (WHO) declared a Public Health Emergency of International Concern (PHEIC) on May 16-17, underscoring the severe risk of regional transmission, particularly from the epicenter in DRC Ituri Province. Compounding the public health challenge, the outbreak is unfolding amidst a complex humanitarian crisis, ongoing armed conflict in eastern DRC, and widespread population displacement, making traditional containment measures like contact tracing and safe burials exceptionally difficult to implement effectively. The Africa CDC and WHO have jointly launched a six-month, $518 million response plan to bolster surveillance, laboratory testing, and infection prevention, yet the virus's spread in regions like Kampala highlights the precarious cross-border transmission risks. Experts from the U.S. Centers for Disease Control and Prevention (CDC) warn that without robust public health interventions, the outbreak could balloon to 10,000 to 20,000 cases within three months, mirroring the devastating 2014-2016 West Africa epidemic. While the Coalition for Epidemic Preparedness Innovations (CEPI) fast-tracks vaccine candidates for BDBV, the immediate future hinges on overcoming infrastructural, security, and community trust barriers to curb this lethal pathogen's unchecked expansion.